However, contradictory evidence from a publication by Han and Crowe shows that in the MMTV-neu background, JNK1 expression is high and inhibiting JNK1 increased tumor latency and decreased tumor growth [29], indicating that pro-tumorigenic functions for JNK could also exist in neu-driven mammary cancers. This evidence concerns the gene ERBB2 and breast cancer.